Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04468204 · ClinicalTrials.gov registry record · NA

Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory Infection (URI)

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
95
Enrollment target

NCT04468204 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 95 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04468204, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target

Study Summary

This study aims to test the safety, efficacy and potential mechanism of action of the SinuSonic device on adults with upper respiratory infection (URI). SinuSonic is a medical device that utilizes sound and pressure combined with normal breathing. The study will have 2 aims. Aim 1 willdetermine if Sinusonic decreases the number of URIs experienced during an 8 week fall URI season. Subjects will use an active device (positive expiratory pressure and 128 Hz) or a sham device (no positive expiratory pressure and 1,000 Hz) for 1 min tid for 8 weeks. Aim 2 will determine if Sinusonic decreases the severity and duration of community acquired viral URIs. Subjects will use active or sham device as above.

Interventions

  • DEVICE SinuSonic Device
  • DEVICE Sham SinuSonic Device

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2020-10-01
Est. Completion 2021-07-01
Phase NA

What the Registry Record Tells You About NCT04468204

The ClinicalTrials.gov registry entry for NCT04468204 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which SinuSonic Device is the first listed.

NCT04468204 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04468204 about?

NCT04468204 is a clinical study titled "Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory Infection (URI)". This study aims to test the safety, efficacy and potential mechanism of action of the SinuSonic device on adults with upper respiratory infection (URI). SinuSonic is a medical device that utilizes sound and pressure combined with normal breathing. The study will have 2 aims. Aim 1 willdetermine if S...

What is the current status of trial NCT04468204?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2020-10-01. Estimated completion is 2021-07-01.

What interventions are being tested in trial NCT04468204?

The interventions under investigation include: SinuSonic Device (DEVICE), Sham SinuSonic Device (DEVICE).

Who is sponsoring clinical trial NCT04468204?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.